Avricore Health Corporate Update – Mid-Year Review Demonstrates Company on Right Track
VANCOUVER, British Columbia, Aug. 30, 2023 (GLOBE NEWSWIRE) — AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) continues to achieve significant growth, new partnerships and developing new markets while surpassing margin targets. Now, as the Company looks back at the first half of the year, it continues with confidence on its strategy to bring HealthTab™, its turnkey solution for point of care testing and data management, to more pharmacies across Canada and the world.
Related news for (AVCRF)
- AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY
- Avricore Health Corporate Update and Audited Results for 2023
- HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations
- Avricore Health Corporate Update – Company Demonstrates Strong Growth
- HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic